Oleic Acid and Oleoylethanolamide Decrease Interferon-γ-induced Expression of PD-L1 and Induce Apoptosis in Human Lung Carcinoma Cells
Overview
Affiliations
Inhibition of programmed death-ligand 1 (PD-L1) in cancer cells provides a reasonable avenue to prevent cancer progression. Although oleate is known to exert anti-cancer effects, its PD-L1 inhibitory effects have not been proven. This study investigated the effects of oleic acid and an oleic acid metabolite, oleoylethanolamide (OEA), on PD-L1 expression and biomarkers of tumorigenesis in several cancer cell lines, namely A549, HuH-7, MCF-7, DLD-1, and LoVo cells. Specifically, we analyzed the expression of PD-L1 and several apoptosis-related genes using RT-PCR. Interferon-gamma (IFN-γ)-induced modulation of PD-L1 protein expression was investigated using western blotting. Results indicate that IFN-γ stimulation increased the expression of PD-L1 in the chosen cancer cell lines. The IFN-γ-induced expression of PD-L1 was greater in A549 cells, than in other cancerous cell lines. In A549 cells, oleic acid and OEA decreased IFN-γ-induced expression of PD-L1, Bax, Bcl-2, and caspase 3. Oleic acid and OEA decreased IFN-γ-induced phosphorylation of STAT. These results indicate that oleic acid and OEA inhibit PD-1 expression, and induce apoptosis via STAT phosphorylation. Therefore, oleic acid and OEA may prevent cancer formation through STAT phosphorylation with IFN-γ. These findings provide novel insights into the anti-cancer effects of oleic acid-rich oil, such as olive oil.
The Impact of Polyunsaturated Fatty Acids in Cancer and Therapeutic Strategies.
Yan D, Hou Y, Lei X, Xiao H, Zeng Z, Xiong W Curr Nutr Rep. 2025; 14(1):46.
PMID: 40085324 DOI: 10.1007/s13668-025-00639-y.
DPP3 promotes breast cancer tumorigenesis by stabilizing FASN and promoting lipid synthesis.
Fu X, Li X, Wang W, Li J Acta Biochim Biophys Sin (Shanghai). 2024; 56(5):805-818.
PMID: 38655619 PMC: 11177116. DOI: 10.3724/abbs.2024054.
Camoglio C, Balla J, Fadda P, Dedoni S Molecules. 2024; 29(7).
PMID: 38611871 PMC: 11013881. DOI: 10.3390/molecules29071592.
Zhou Y, Wang F, Li G, Xu J, Zhang J, Gullen E Front Immunol. 2024; 15:1340307.
PMID: 38426097 PMC: 10902058. DOI: 10.3389/fimmu.2024.1340307.
Deng B, Kong W, Suo H, Shen X, Newton M, Burkett W Cancers (Basel). 2023; 15(22).
PMID: 38001668 PMC: 10670880. DOI: 10.3390/cancers15225407.